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pathology in atypical parkinsonism. 
Simply asking about cycling abilities 
could be added to the list of red ﬂ ags 
that can assist clinicians in their early 
diﬀ erential diagnosis of parkinsonism.
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prehensive neurological assess ment, 
and cerebral MRI. The interview 
included a standard question about 
whether, when, and why cycling had 
become impossible. The gold standard 
was the diagnosis after 3 years, which 
was based on the clinical follow-up 
including repeat neurological examin-
ation, response to treatment, and MRI. 
All assessments were done by a single, 
experienced examiner. All patients 
gave informed consent, as approved 
by the local ethics committee.
Before their ﬁ rst disease manifest-
ation, 111 patients rode a bicycle 
(table). 45 went on to develop a gold-
standard diagnosis of Parkinson’s 
disease and 64 a form of atypical 
parkinsonism. At the time of inclusion 
(median disease duration 30 months), 
34 of the 64 patients with atypical 
parkinsonism had stopped cycling, as 
opposed to only two of the 45 patients 
with Parkinson’s disease (sensitivity 
52%, speciﬁ city 96%; AUC 0·74, 
95% CI 0·64–0·83). The loss of cycling 
abilities was present for all forms of 
atypical parkinsonism. Regression 
analysis revealed no signiﬁ cant eﬀ ect 
of age, parkinsonism, or ataxia on the 
ability to cycle, suggesting that this 
was an independent marker of atypical 
parkinsonism.
We suggest that loss of the ability 
to cycle after disease onset might 
serve as a new red ﬂ ag, signalling the 
presence of atypical parkinsonism. The 
diagnostic value of the “bicycle sign” 
was good: its presence was highly 
speciﬁ c for the diagnosis of atypical 
parkinsonism. This observation 
does not stand alone. Patients with 
Parkinson’s disease have few balance 
problems moving sideways,2 their 
gait is typically narrow-based,3 their 
tandem gait is usually normal,4 and 
they can show a remarkable ability 
to ride a bicycle.5 Cycling requires a 
highly coordinated interplay between 
balance, coordination, and rhythmic 
pedalling of the legs. This skilled task is 
probably sensitive to subtle problems 
with balance or coordination, caused 
by the more extensive extranigral 
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the AQUAMAT group. Artesunate versus quinine 
in the treatment of severe falciparum malaria in 
African children (AQUAMAT): an open-label, 
randomised trial. Lancet 2010; 376: 1647–57—
In this Article (Nov 13), the row in table 2 for 
death or sequelae at 28 days in the quinine 
group should have been: 316/2695 (11·7%). 
In table 1, the data in parentheses for coma 
depth are IQR. The last line of the legend for 
ﬁ gure 3 should have read: “I² denotes the 
percentage of total variation across subgroups 
resulting from heterogeneity rather than 
chance, with the p value of signiﬁ cance”. The 
title of ﬁ gure 5 should have read: 
“Meta-analysis of all randomised controlled 
trials that have compared mortality of severe 
malaria in patients treated with parenteral 
artesunate versus parenteral quinine12–16”. 
These corrections have been made to the 
online version as of Jan 7, 2011.
Study of the Eﬀ ectiveness of Additional 
Reductions in Cholesterol and Homocysteine 
(SEARCH) Collaborative Group. Intensive lowering 
of LDL cholesterol with 80 mg versus 20 mg 
simvastatin daily in 12 064 survivors of 
myocardial infarction: a double-blind randomised 
trial. Lancet 2010; 376: 1658–69—In the 
Results section of this Article (Nov 13), the risk 
ratio for coronary revascularisation presented 
in the ﬁ fth paragraph should have been 0·93 
(0·83–1·04), and in ﬁ nal sentence of this 
paragraph, the percentage of patients 
allocated 20 mg simvastatin reported to have 
had transient cerebral ischaemic attacks was 
2·5%. In the seventh paragraph of this section, 
the numbers of female breast cancers in the 
other trials of statin versus control should 
have been 194 (1·0%) vs 187 (1·0%). 
Furthermore, the second sentence of the ﬁ nal 
paragraph of the Results section should have 
read “New diabetes was reported by 625 
(11·6%) participants allocated 80 mg 
simvastatin versus 587 (10·9%) allocated 
20 mg simvastatin (RR 1·07, 0·95–1·19)”. In 
the second paragraph of the Discussion, the 
p value for comparison of non-vascular deaths 
on 80 mg versus 10 mg atorvastatin should 
have been 0·06. These corrections have been 
made to the online version as of Nov 25, 2010.
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